Our leadership
Learn more
Federal legislation is the best opportunity to compel pharmacy benefit managers (PBMs) to change. Neither a major Federal Trade Commission (FTC) settlement nor reforms at the state level have fixed market distortions. But the upcoming US midterm elections in November may break the impasse and enable federal PBM reform to pass.
To understand why, it helps to start with how Americans get their medicines, which looks very different from the NHS model familiar to British readers.
Read the full article at lifesciencedaily.news.